Skip to main content
AMP 2025 Annual Meeting & Expo Main banner
Final Program


  1. Home

  • Thursday, Nov 13th
    10:15 AM - 10:45 AM EST
    Decoding RNA Biology in Space: Toward the Future of Molecular Pathology
    Location: 253ABC, Level 2
    Breakout Speaker: Rong Fan, PhD (he/him/his) – Yale University
     CE: NOT CME/CMLE
  • Thursday, Nov 13th
    10:45 AM - 11:15 AM EST
    Epigenomics in the Clinical Setting: How DNA Methylation Episignatures Aid Diagnosis of Genetic Disorders
    Location: 253ABC, Level 2
    Breakout Speaker: Matthew L. Tedder, PhD (he/him/his) – Greenwood Genetic Center
     CE: NOT CME/CMLE
  • Thursday, Nov 13th
    11:15 AM - 11:45 AM EST
    Proteomic Approaches to Molecular Diagnostics
    Location: 253ABC, Level 2
    Breakout Speaker: Michael Gillette, MA,MSc,MD, PhD (he/him/his) – Broad Institute of MIT and Harvard
     CE: NOT CME/CMLE
  • Friday, Nov 14th
    1:15 PM - 1:45 PM EST
    Opportunities and Challenges With Implementing ACMG Secondary Findings
    Location: 258ABC, Level 2
    Breakout Speaker: David T Miller, MD, PhD (he/him/his) – Boston Children's Hospital
     CE: 1.5
  • Friday, Nov 14th
    1:45 PM - 2:15 PM EST
    Navigating Ethical Issues in Implementing Polygenic Risk Score Screening
    Location: 258ABC, Level 2
    Breakout Speaker: Anna C F Lewis, PhD (she/her/hers) – Brigham and Women's Hospital
     CE: 1.5
  • Friday, Nov 14th
    2:15 PM - 2:45 PM EST
    Opportunities/Challenges of Implementing Pre-emptive Pharmacogenomic Testing
    Location: 258ABC, Level 2
    Breakout Speaker: Peter H. O'Donnell, MD – The University of Chicago
     CE: 1.5
  • Friday, Nov 14th
    3:45 PM - 5:15 PM EST
    Genetics Plenary
    Location: Grand Ballroom, Level 3
    Program Committee Moderator: Sherin Shaaban, MD, PhD, FACMG – University of Utah
    Program Committee Moderator: Stuart A. Scott, PhD – Stanford
     CE: 1.5
  • Friday, Nov 14th
    3:45 PM - 5:15 PM EST
    Confronting the Variants of Uncertain Significance (VUS) Conundrum
    Location: Grand Ballroom, Level 3
    Plenary Speaker: Heidi L. Rehm, PhD (she/her/hers) – Massachusetts General Hospital and Broad Institute of MIT and Harvard
     CE: 1.5
  • Saturday, Nov 15th
    2:30 PM - 3:00 PM EST
    Identifying Germline Variants in Pediatric Patients With Solid Tumors
    Location: 156ABC, Level 1
    Breakout Speaker: Minjie Luo, PhD (she/her/hers) – Children's Hospital of Philadelphia
     CE: 1.5
  • Saturday, Nov 15th
    3:00 PM - 3:30 PM EST
    Insights into Hereditary Cancer Predisposition from Tumor-Normal Sequencing: the MSK-IMPACT Experience
    Location: 156ABC, Level 1
    Breakout Speaker: Diana Mandelker, MD, PhD – Memorial Sloan Kettering Cancer Center
     CE: 1.5
  • Saturday, Nov 15th
    3:30 PM - 4:00 PM EST
    Putting Precision Medicine into Practice for Prostate Cancer: Impact of Genetic Testing on Cancer Risk and Treatment
    Location: 156ABC, Level 1
    Breakout Speaker: Patrick Pilie, MD – MD Anderson Cancer Center
     CE: 1.5